报价延迟最少15分钟:2026/07/23 14:47 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.38 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-5.63/--
|
|
企业价值
6.28M
|
| 资产负债 |
|
每股账面净值
7.98
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
45.72K
|
|
每股收益
0.03
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietarysignal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. |
